Paclitaxel-based therapy in non-small-cell lung cancer: Improved third generation chemotherapy
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/10/suppl_5/S63/6672494/10-suppl_5-S63.pdf
Reference29 articles.
1. Multidisciplinary approach to potentially curable non-small-cell carcinoma of the lung;Greco;Oncology,1997
2. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer: Report of a Canadian multicenter randomized trial;Rapp;J Clin Oncol,1988
3. A randomized trial of cisplatin and vindesine versus supportive care only in advanced non-small-cell lung cancer;Woods;Br J Cancer,1990
4. Supportive care versus supportive care and combination chemotherapy in metastatic non-small-cell lung cancer: Does chemotherapy make a difference?;Ganz;Cancer,1989
5. A randomized trial of alternating chemotherapy versus best supportive care in adjuvant non-small-cell lung cancer;Cellerino;J Clin Oncol,1991
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Derivation of a new model of lung adenocarcinoma using canine lung cancer organoids for translational research in pulmonary medicine;Biomedicine & Pharmacotherapy;2023-09
2. Temporal trends and predictors of perioperative chemotherapy use in elderly patients with resected nonsmall cell lung cancer;Cancer;2008
3. A Phase II Randomized Study of Paclitaxel Plus Carboplatin or Cisplatin against Chemo-Naive Inoperable Non-small Cell Lung Cancer in the Elderly;Journal of Thoracic Oncology;2006-02
4. A Phase II Randomized Study of Paclitaxel Plus Carboplatin or Cisplatin against Chemo-Naive Inoperable Non-small Cell Lung Cancer in the Elderly;Journal of Thoracic Oncology;2006-02
5. Paclitaxel plus carboplatin, compared with paclitaxel plus gemcitabine, shows similar efficacy while more cost-effective: a randomized phase II study of combination chemotherapy against inoperable non-small-cell lung cancer previously untreated;Annals of Oncology;2002-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3